Baseline characteristics and response to evinacumab in females and males with homozygous familial hypercholesterolemia in the ELIPSE OLE study.

Am J Prev Cardiol · 2026 · PMC12946892 · PMID 41767444

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Equivalent results were observed with lomitapide treatment in the Pan-European Lomitapide Study [ 24 ], which also showed a trend toward a greater reduction in LDL-C in HoFH female compared with males after 6 months of lomitapide treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.